EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Inflammation and Regeneration

ISSN 1880-8190 · Springer Science and Business Media LLC

Latest articles

  1. Safety and efficacy profile of S-005151 (Redasemtide), in patients with chronic liver diseases: phase 2 trial

    Atsunori Tsuchiya, Yusuke Watanabe, Naruhiro Kimura, Hiroyuki Abe, Toru Setsu, Takeshi Yokoo, Hiroteru Kamimura, Akira Sakamaki, Hiroaki Saito, Masaki Tominaga, Tatsuhiko Sato, Nobutaka Kitamura, Takahiro Tanaka, Yoshitomi Kanemitsu, Masahiro Ishizawa, Haruna Miyazawa, Mototsugu Tanaka, Hiroyuki Ishikawa, Kenichi Harada, Yoshihiko Tomita, Katsuto Tamai, Shuji Terai

    Published: 2026-05-09DOI: 10.1186/s41232-026-00421-9

Volumes

2026 · 502025 · 372024 · 502023 · 622022 · 652021 · 352020 · 412019 · 202018 · 312017 · 262016 · 262015 · 392014 · 342013 · 382012 · 332011 · 562010 · 372009 · 342008 · 382007 · 372006 · 25

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.